Epstein Secrets

he refuses to concede the election." According to the AP, Trump "said a vaccine would ship in `a matter of weeks' to vulnerable populations, though the Food and Drug Administration has not yet been asked to grant the necessary emergency approvals." The AP says, "Public health experts worry that Trump's refusal to take aggressiv

addition, The Hill <https://thehill.com/homenews/news/526011-moore-trump-is-a- little-grouchy-over-election-results> (11/15, Williams, 2.98M) reports Stephen Moore, an economist and adviser to Trump, in an interview with WABC-AM "said the president is 'a little grouchy' over the results of the election," but "

he refuses to concede the election." According to the AP, Trump "said a vaccine would ship in 'a matter of weeks' to vulnerable populations, though the Food and Drug Administration has not yet been asked to grant the necessary emergency approvals." The AP says, "Public health experts worry that Trump's refusal to take aggressi

a second term, saying there would be a `smooth transition to a second Trump administration." In addition, The Hill (11/15, Williams, 2.98M) reports Stephen Moore, an economist and adviser to Trump, in an interview with WABC-AM "said the president is `a little grouchy' over the results of the election," but "

he refuses to concede the election." According to the AP, Trump "said a vaccine would ship in 'a matter of weeks' to vulnerable populations, though the Food and Drug Administration has not yet been asked to grant the necessary emergency approvals." The AP says, "Public health experts worry that Trump's refusal to take aggressi

a second term, saying there would be a `smooth transition to a second Trump administration." In addition, The Hill (11/15, Williams, 2.98M) reports Stephen Moore, an economist and adviser to Trump, in an interview with WABC-AM "said the president is `a little grouchy' over the results of the election," but "

he refuses to concede the election." According to the AP, Trump "said a vaccine would ship in 'a matter of weeks' to vulnerable populations, though the Food and Drug Administration has not yet been asked to grant the necessary emergency approvals." The AP says, "Public health experts worry that Trump's refusal to take aggressi

a second term, saying there would be a `smooth transition to a second Trump administration." In addition, The Hill (11/15, Williams, 2.98M) reports Stephen Moore, an economist and adviser to Trump, in an interview with WABC-AM "said the president is `a little grouchy' over the results of the election," but "

ecretary. Economic advisers that have represented Trump on the campaign include investor Wilbur Ross and economists Peter Navarro, Larry Kudlow, and Stephen Moore. New Jersey Gov. Chris Christie is in charge of Trump’s transition. Politicians who have supported and served as surrogates for Trump and could poss

eauthorized in 2017 to ensure that sufficient industry fees are available for the FDA to continue to consider the applications of drugs and devices. The Food and Drug Administration (FDA) and relevant industries have reached draft agreements on the user fee proposals. The proposals are historically bipartisan priorities and are e